ISPOR Europe
Vienna, Austria, Nov 8-11, 2026
Find CDA at Booth #723
- Monday, Nov 9: 9:30-19:00
- Tuesday, Nov 10: 9:30-19:00
- Wednesday, Nov 11: 8:30-11:30
Poster Presentations
Monday
Session 1 Discussion: 12:30-13:30
- CO28: Projected impact of personalized mRNA neoantigen vaccines on melanoma recurrence in Medicare beneficiaries: A parametric survival and threshold cost-effectiveness analysis
Session 2 Discussion: 18:00-19:00
- CO73: The hidden cost of waiting: Earlier CAR T access reduces 5-year total spending in relapsed/refractory diffuse large B cell lymphoma
Tuesday
Session 3
Poster Tour Presentation: 11:45-12:30
- PT26: Glucagon-like peptide-1-based anti-obesity medications reduce incident Obstructive Sleep Apnea in Older Adults: Real-World Evidence TOP 5%
- Real-world utilization of talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer in the United States
-
Treatment patterns, healthcare resource utilization and costs among patients with tenosynovial giant cell tumor (TGCT) in the United States
Learn more about ISPOR Europe.
Find more CDA presentations and publications here.
